Statistical Power of Two Quantitative Biomarkers for Analysis of DCE-MRI Studies of Agents Targeting Tumour Vasculature

The PPAR? Inhibitor GW9662 Attenuates Phenylbutyrate-Induced Lipid Metabolite Accumulation in DU145 Prostate Cancer Cells